Mindful-Breath for People With COPD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorThe University of Hong Kong

About this trial

Individuals living with chronic obstructive pulmonary disease (COPD) often suffer from stress and behavioral risks such as physical inactivity. In an attempt to promote healthy behaviors and overall wellbeing among this particular population, this study aims to develop and evaluate a personalized Mindful-Breath intervention combining telehealth technology and mindfulness for COPD patients. This is an assessor-blinded, two-arm exploratory randomized controlled trial with a sequential mixed-method design. A total of 60 participants will be recruited and randomly assigned to either intervention or control group using 1:1 ratio. Intervention group will go through 8 weekly 60-min hybrid group sessions, combining mindfulness-based pulmonary rehabilitation and lifestyle modification. Personalized mindfulness-based lifestyle counselling through instant messages with chat-based support throughout the 8-week intervention period will also be provided. Control group will receive a single in-person 60-min group session on general education on pulmonary rehabilitation and lifestyle modification and will only receive reminder messages for follow-ups. Variables such as time spent on physical activity, lung function, perceived stress, symptom burden and health-related quality of life will be collected at three time-points (T0: baseline, prior to randomization; T1: immediate post-intervention; T2: 3-month post-intervention).

Eligibility criteria

Qualifiers

Age: 50-80 years

Sex: Male or female

Education level: Primary or above

Diagnosis: COPD (Baseline FEV1 <80% and FEV1/FVC <70% of predicted normal values)

Disqualifiers

Engaging in >60 minutes/week of moderate PA based on American Lung Association guidelines

Recent or ongoing receipt of other pharmacological/behavioral trials within the past 3 months

Contraindications or severe comorbidities that may limit full participation (mental diseases, deafness, limb activity disorder, coronary heart disease, arterial aneurysm, uncontrolled hypertension, pregnancy, etc)

Co-existing respiratory diseases (Asthma/interstitial lung disease/bronchiectasis) or active malignancies

Trial design

Treatments tested in this trial

  • Hybrid Mindfulness-Based Group Sessions
  • Ecological Momentary Interventions (EMI)
  • Single General Education on Pulmonary Rehabilitation and Lifestyle Modification Group
  • Activity Monitoring

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The University of Hong Kong

Lead sponsor

Health and Medical Research Fund

Collaborator